Animal study shows β-carotene supplementation reduces triglyceride levels in type 2 diabetes models, suggesting potential metabolic benefits.
Background: Hypertriglyceridemia is associated with decreasing insulin sensitivity and increasing insulin resistance in type 2 diabetes mellitus. β-carotene has a cytoprotective effect that can improve and protect β-cells of the pancreas, resulting in increased insulin synthesis and secretion. β-carotene prevents the deleterious effects of uncontrolled glucose and lipid metabolism. Objectives: This research aimed to investigate the effect of β-carotene supplementation on triglyceride levels in high-fat diet and streptozotocin-nicotinamide induced Type 2 Diabetes Mellitus Wistar Rats. Methods: 18 Wistar rats were randomly divided into three groups: X1 (negative controls), X2 (positive controls), and X3 (STZ-NA+β-carotene 10 mg/KgBW). High-fat diet intervention was given 14 days before diabetic induction in X2 and X3 groups; the negative control group X1 was given standard feed. To condition Wistar rats to be type 2 Diabetes Mellitus, rats in groups X2 and X3 received intraperitoneal injections of Streptozotocin at a dose of 45 mg/KgBW and nicotinamide at a dose of 110 mg/kgBW. Supplementation of β-carotene was given by the nasogastric feeding tube method every 2 days within 30 days. Plasma Triglyceride levels were measured using GPO-PAP. The effect of triglyceride levels after β-carotene supplementation was tested with a statistical test using a paired t-test and one-way ANOVA. Results: Blood glucose levels in groups X2 and X3 increased by 188.34 g/dl and 186.34 g/dl after being injected with STZ and NA. There was a significant effect of triglyceride levels (p-value<0.001) after supplementation with β-carotene at a dose of 10 mg/kgBW. Serum triglyceride levels decreased by a mean of 21.90% or 28.42 mg/dl. Conclusions: This research revealed that the supplementation of β-carotene at a dose of 10 mg/kgBW every 2 days within 30 days by the nasogastric feeding tube method can lower triglyceride levels in diabetic Wistar rats.
No takes yet. Share an insight, caveat, or question.
Soviana et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: